72 related articles for article (PubMed ID: 1731051)
21. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
Docherty JR
J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
[TBL] [Abstract][Full Text] [Related]
22. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
23. Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).
Hirst WD; Andree TH; Aschmies S; Childers WE; Comery TA; Dawson LA; Day M; Feingold IB; Grauer SM; Harrison BL; Hughes ZA; Kao J; Kelly MG; van der Lee H; Rosenzweig-Lipson S; Saab AL; Smith DL; Sullivan K; Rizzo SJ; Tio C; Zhang MY; Schechter LE
J Pharmacol Exp Ther; 2008 Apr; 325(1):134-45. PubMed ID: 18182558
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
[TBL] [Abstract][Full Text] [Related]
25. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
[TBL] [Abstract][Full Text] [Related]
26. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
Sheldon PW; Aghajanian GK
Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
[TBL] [Abstract][Full Text] [Related]
27. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat.
Docherty JR; Warnock P
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S59-61. PubMed ID: 2446073
[TBL] [Abstract][Full Text] [Related]
28. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
Lucki I; Nobler MS; Frazer A
J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
[TBL] [Abstract][Full Text] [Related]
29. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
Marek GJ; Li AA; Seiden LS
J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
[TBL] [Abstract][Full Text] [Related]
30. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008
[TBL] [Abstract][Full Text] [Related]
31. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K
Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
33. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH
Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541
[TBL] [Abstract][Full Text] [Related]
34. The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist.
Rënyi L; Evenden JL; Fowler CJ; Jerning E; Kelder D; Lake-Bakaar D; Larsson LG; Mohell N; Sällemark M; Ross SB
J Pharmacol Exp Ther; 2001 Dec; 299(3):883-93. PubMed ID: 11714872
[TBL] [Abstract][Full Text] [Related]
35. Response suppression induced with selective 5-HT agonists can be differentially blocked with LY53857 in an animal model of depression.
Engleman EA; Murphy JM; Zhou FC; Hingtgen JN
Neurochem Res; 1992 May; 17(5):483-8. PubMed ID: 1388251
[TBL] [Abstract][Full Text] [Related]
36. Comparative 5-HT2-receptor antagonist activity of amesergide and its active metabolite 4-hydroxyamesergide in rats and rabbits.
Cohen ML; Kurz KD; Fuller RW; Calligaro DO
J Pharm Pharmacol; 1994 Mar; 46(3):226-9. PubMed ID: 8027933
[TBL] [Abstract][Full Text] [Related]
37. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
Fuller RW; Snoddy HD
Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
[TBL] [Abstract][Full Text] [Related]
38. The role of the 5-HT2 receptor in the regulation of sexual performance of male rats.
Foreman MM; Hall JL; Love RL
Life Sci; 1989; 45(14):1263-70. PubMed ID: 2811596
[TBL] [Abstract][Full Text] [Related]
39. Serotonergic agonists and antagonists affect endurance performance in the rat.
Bailey SP; Davis JM; Ahlborn EN
Int J Sports Med; 1993 Aug; 14(6):330-3. PubMed ID: 8407063
[TBL] [Abstract][Full Text] [Related]
40. Effects of fenfluramine and para-chloroamphetamine on sexual behavior of male rats.
Foreman MM; Hall JL; Love RL
Psychopharmacology (Berl); 1992; 107(2-3):327-30. PubMed ID: 1615133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
